Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.

Authors

Meredith L Stone
Katherine B Chiappinelli, George Washington UniversityFollow
Huili Li
Lauren M Murphy
Meghan E Travers
Michael J Topper
+several additional authors

Document Type

Journal Article

Publication Date

12-19-2017

Journal

Proceedings of the National Academy of Sciences of the United States of America

Volume

114

Issue

51

Inclusive Pages

E10981-E10990

DOI

10.1073/pnas.1712514114

APA Citation

Stone, M., Chiappinelli, K., Li, H., Murphy, L., Travers, M., Topper, M., & +several additional authors (2017). Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.. Proceedings of the National Academy of Sciences of the United States of America, 114 (51). http://dx.doi.org/10.1073/pnas.1712514114

Peer Reviewed

1